Blood Pressure Clinical Trials Dispensary 
SpeedWeed
AUGUST 3, 2021
To learn more about THC-O acetate, Cannabis Business Times , Cannabis Dispensary and Hemp Grower spoke with board-certified neurologist Ethan Russo, M.D., Had what’s called a vasovagal syncope [a sudden drop in heart rate and blood pressure that leads to fainting] from too-high a dose of THC. It remains to be seen.
SpeedWeed
AUGUST 5, 2021
To learn more about THC-O acetate, Cannabis Business Times , Cannabis Dispensary and Hemp Grower spoke with board-certified neurologist Ethan Russo, M.D., Had what’s called a vasovagal syncope [a sudden drop in heart rate and blood pressure that leads to fainting] from too-high a dose of THC. It remains to be seen.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SpeedWeed
AUGUST 4, 2021
To learn more about THC-O acetate, Cannabis Business Times , Cannabis Dispensary and Hemp Grower spoke with board-certified neurologist Ethan Russo, M.D., Had what’s called a vasovagal syncope [a sudden drop in heart rate and blood pressure that leads to fainting] from too-high a dose of THC. It remains to be seen.
SpeedWeed
AUGUST 4, 2021
To learn more about THC-O acetate, Cannabis Business Times , Cannabis Dispensary and Hemp Grower spoke with board-certified neurologist Ethan Russo, M.D., Had what’s called a vasovagal syncope [a sudden drop in heart rate and blood pressure that leads to fainting] from too-high a dose of THC. It remains to be seen.
SpeedWeed
AUGUST 4, 2021
To learn more about THC-O acetate, Cannabis Business Times , Cannabis Dispensary and Hemp Grower spoke with board-certified neurologist Ethan Russo, M.D., Had what’s called a vasovagal syncope [a sudden drop in heart rate and blood pressure that leads to fainting] from too-high a dose of THC. It remains to be seen.
Project CBD
AUGUST 6, 2019
Harvard University scientist Staci Gruber shared encouraging results from “the first open-label to double-blind clinical trial” assessing the impact of a high- CBD , low- THC sublingual tincture in patients who experience moderate anxiety. None of the participants had been using any cannabinoid-based products prior to this study.
Project CBD
AUGUST 6, 2019
Harvard University scientist Staci Gruber shared encouraging results from “the first open-label to double-blind clinical trial” assessing the impact of a high- CBD , low- THC sublingual tincture in patients who experience moderate anxiety. None of the participants had been using any cannabinoid-based products prior to this study.
Expert insights. Personalized for you.
58 
Let's personalize your content